Japanese court reaches deal over contamination:
This article was originally published in Clinica
Executive Summary
Over 200 people infected with HIV from contaminated blood could be awarded ¥5 million ($450,000) each, a Japanese court has ruled. Legal proceedings were brought in 1989 by 220 victims of contaminated blood imported from the US. The court estimated that the Japanese government should provide 40% of indemnification funds, with the remaining 60% being paid by drug companies, says Le Quotidien du Medecin.
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.